SCHEMBL8627702

SCHEMBL8627702

Nn1c(S)nnc1-c1ccccc1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
LMNA P02545 5/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
HSD17B10 Q99714 3/20 0.40
NR1I2 O75469 2/20 0.39
SMARCA2 P51531 2/20 0.39
SMARCA4 P51532 2/20 0.39
PBRM1 Q86U86 2/20 0.39
BRD4 O60885 1/20 0.39
KMT2A Q03164 4/20 0.38
KDM4A O75164 1/20 0.38
HPGD P15428 2/20 0.36
BCL2L1 Q07817 1/20 0.36
IDO1 P14902 1/20 0.36
MEN1 O00255 3/20 0.36
MAPT P10636 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16675470 0.80 LMNA (0.47) ALDH1A1LMNASMN1; SMN2NPC1RAB9A
SCHEMBL4350463 0.80 ALDH1A1 (0.48) ALDH1A1LMNASMN1; SMN2NPC1RAB9A
SCHEMBL4349748 0.80 ALDH1A1 (0.47) ALDH1A1LMNASMN1; SMN2NPC1RAB9A
SCHEMBL4944318 0.79 ALDH1A1 (0.46) ALDH1A1LMNASMN1; SMN2NPC1RAB9A
SCHEMBL8628370 0.79 HSD11B1 (0.46) ALDH1A1LMNASMN1; SMN2RAB9AHSD17B10
SCHEMBL4345607 0.79 ALDH1A1 (0.76) ALDH1A1LMNASMN1; SMN2NPC1RAB9A
SCHEMBL10012799 0.79 HSD11B1 (0.46) ALDH1A1LMNASMN1; SMN2NPC1RAB9A
SCHEMBL4489888 0.75 ALDH1A1 (0.42) ALDH1A1LMNASMN1; SMN2NPC1RAB9A
SCHEMBL4352521 0.75 ALDH1A1 (0.42) ALDH1A1LMNASMN1; SMN2NPC1RAB9A
SCHEMBL2889816 0.75 KDM4E (0.52) ALDH1A1LMNASMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11737462-B2 Methods for modulating plant response to environmentally-induced stress HOWARD UNIVERSITY (US) 2023-08-29 US disclosed
US-11737462-B2 Methods for modulating plant response to environmentally-induced stress HOWARD UNIVERSITY (US) 2023-08-29 US disclosed
US-20150119250-A1 METHODS FOR MODULATING PLANT RESPONSE TO ENVIRONMENTALLY-INDUCED STRESS GEORGETOWN UNIVERSITY 2015-04-30 US disclosed
US-20150119250-A1 METHODS FOR MODULATING PLANT RESPONSE TO ENVIRONMENTALLY-INDUCED STRESS GEORGETOWN UNIVERSITY 2015-04-30 US disclosed
CN-103288766-A Triazole compound, and preparation method and application thereof INST OCEANOLOGY CHINESE ACAD 2013-09-11 CN disclosed
US-RE35754-E FOR TREATING BACTERIAL INFECTIONS HOECHST AKTIENGESELLSCHAFT (DE) 1998-03-24 US disclosed
US-5710146-A ANTIBIOTICS FOR BACTERICIDES HOECHST AKTIENGESELLSCHAFT (DE) 1998-01-20 US disclosed
US-5089490-A Cephem derivatives HOECHST AKTIENGESELLSCHAFT (DE) 1992-02-18 US disclosed
US-4758556-A Cephem derivatives HOECHST AKTIENGESELLSCHAFT (DE) 1988-07-19 US disclosed
US-4278793-A ANTIBIOTICS, BACTERICIDES HOECHST AKTIENGESELLSCHAFT (DE) 1981-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11737462-B2 Methods for modulating plant response to environmentally-induced stress RACK1, ROS1, HSF1 ALDH1A1 2652/4885LMNA 3460/4885SMN1; SMN2 4793/4885
US-20150119250-A1 METHODS FOR MODULATING PLANT RESPONSE TO ENVIRONMENTALLY-INDUCED STRESS RACK1, ROS1, HSF1 ALDH1A1 2652/4885LMNA 3460/4885SMN1; SMN2 4793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.